Iskalni niz:
išči po
išči po
išči po
išči po
Vrsta gradiva:
Jezik:
Št. zadetkov: 3
Prospective observational study of COVID-19 vaccination in patients with thoracic malignancies
Urška Janžič, Andrej Janžič, Abed Agbarya, Urška Bidovec, Katja Mohorčič, Marina Čakš, Peter Korošec, Matija Rijavec, Erik Škof
Izvirni znanstveni članek
Oznake: rak pljuč;onkološko zdravljenje;cepljenje proti COVID-19;neželeni dogodki;prebojna okužba;thoracic malignancies;cancer therapy;COVID-19 vaccination;adverse events;breakthrough infection;
Abstract: Due to the devastating COVID-19 pandemic, a preventive tool in the form of vaccination was introduced. Thoracic cancer patients had one of the highest rates of morbidity and mortality due to COVID-19 disease, but the lack of data about the safety and effectiveness of vaccines in this popul ...
Leto: 2024 Vir: Onkološki inštitut Ljubljana (OI)
Real-world experience in treatment of patients with non-small-cell lung cancer with BRAF or cMET exon 14 skipping mutations
Urška Janžič, Walid Shalata, Katarzyna Szymczak, Rafal Dziadziuszko, Marko Jakopović, Giannis Mountzios, Adam Płużański, António Araújo, Andriani Charpidou, Abed Agbarya
Izvirni znanstveni članek
Oznake: nedrobnocelični pljučni rak;mutacija BRAF V600;podatki iz resničnega življenja;tarčna terapija;zdravljenje prvega reda;non-small-cell lung cancer;BRAF V600 mutation;cMET exon 14 skipping mutation;real-world data;targeted therapy;first-line therapy;
BRAF and cMET exon 14 skipping are rare mutations of NSCLC. The treatment sequence in these cases for the first and second line is not clear. An international registry was created for patients with advanced NSCLC harboring BRAF or cMET exon 14 skipping mutations, diagnosed from January 2017 to June ...
Leto: 2023 Vir: Digitalni repozitorij raziskovalnih organizacij Slovenije
Response rate of the third and fourth doses of the BNT162b2 vaccine administered to cancer patients undergoing active anti-neoplastic treatments
Abed Agbarya, Ina Sarel, Tomer Ziv-Baran, Orna Schwartz, Yelena Shechtman, Ella Kozlener, Rasha Khoury, Mohammad Sheikh Ahmad, Leonard Saiegh, Forat Swaid, Ahmad Asala Abu, Urška Janžič, Ronen Brenner
Izvirni znanstveni članek
Oznake: SARS-CoV-2;BNT162b2 vaccine;cancer patients;anti-neoplastic treatment;chemotherapy;antibodies;immunogenicity;COVID-19;immunocompromise;
Response rate of the third and fourth doses of the BNT162b2 vaccine administered to cancer patients undergoing active anti-neoplastic treatments
Leto: 2023 Vir: Repozitorij Univerze v Ljubljani (RUL)
Št. zadetkov: 3
Ključne besede:
Leto izdaje:
Avtorji:
Repozitorij:
Tipologija:
Jezik: